AR expression has been found to vary across different subtypes of breast cancer, with some studies suggesting that AR-positive tumors may exhibit less aggressive characteristics and be associated with a better prognosis, while AR-negative tumors tend to be more aggressive and harder to treat [56,57,58,59]. Here, AR is linked to breast cancer.